Anti-Aging Effects Of Nanovesicles Derived From Human Tonsil-Derived Mesenchymal Stem Cells

Mar 28, 2023

Abstract: Growing evidence has demonstrated that biomimetic nanovesicles produced from specific cells show bioactive properties such as anti-tumor or anti-inflflammatory activities. However, the properties of these nanovesicles are very diverse, depending on their cell sources. In this study, human tonsil-derived mesenchymal stem cells (TMSCs) were used in the production of functional biomimetic nanovesicles with anti-senescence. TMSCs were isolated from human tonsil tissue obtained by tonsillectomy. TMSC-derived nanovesicles (TMSC-NVs) were produced by serial extrusion using a mini-extruder. Western blotting and particle analysis were performed for the characterization of TMSCNVs. They were applied to both replicative and ultraviolet B-induced senescent human dermal fibroblasts in vitro. Following six days of treatment, analysis of the proliferation and senescence level of fibroblasts was performed using cell counting and senescence-associated β-galactosidase assay, respectively. Treatment with TMSC-NVs enhanced cell proliferation and reduced the activity of senescence-associated β-galactosidase in both replicative and ultraviolet B-induced senescent cells. 

Treatment with TMSC-NVs resulted in increased expression of extracellular matrix and anti-oxidant genes. Treatment with TMSC-NVs resulted in reduced expression of vinculin in focal adhesion. These results show that TMSC-NVs have an effect on recovering from cellular senescence by oxidative stress and can be applied as useful materials for the development of skin rejuvenation. 


Keywords: human tonsil-derived mesenchymal stem cells; biomimetic nanovesicle; skin rejuvenation 


1. Introduction

Aging is characterized by time-dependent loss of function and regenerative properties of organisms. Factors related to skin aging cause damage to cells, delaying skin regeneration and cell proliferation, known as cellular senescence. Cellular senescence is characterized by an irreversible arrest of the cell cycle [1] and alteration of the focal adhesive cytoskeleton [2,3]. Cellular senescence in skin tissues is induced by various factors, such as oxidative stress [4,5], mitochondrial dysfunction [6,7], and ultraviolet irradiation [8,9]. For the past several decades, many researchers have been conducting research to overcome cellular senescence for skin regeneration. 

Recently, to overcome cellular senescence, many studies have focused on the tissue regenerative potential of exosomes. Exosomes, which are known as nano-size biomimetic nanovesicles secreted across the plasma membrane from the originated cells by the endocytic pathway [10,11], contains several components, including miRNA, mRNA, and proteins [12–14]. In addition, exosomes have been studied for skin rejuvenation and anti-aging approaches. For example, Choi et al. demonstrated that exosomes derived from adipose-derived mesenchymal stem cells promote the proliferation and migration of human dermal fibroblasts (HDFs) [15]. Kim at el. demonstrated that the exosomes secreted from induced pluripotent stem cell-derived mesenchymal stem cells increase the proliferation of HDFs and HaCaT (immortalized human keratinocytes) [16]. Human umbilical cord blood stem cell-derived exosomes were studied for cutaneous wound healing via stimulation of the Wnt signaling pathway [17] and skin rejuvenation [18]. 

cistanche for skin aging

Buy Cistanche For Skin Rejuvenation

However, despite the potential of exosomes for therapeutic purposes, there are several hurdles, including low efficiency, long procedure time, and high technical expertise [19]. To overcome those hurdles, many researchers have focused on the direct production of exosome-mimetic nanovesicles from somatic cells [20–23]. These biomimetic nanovesicles can be directly isolated from the desired cells by sonication and/or extrusion and are reported to share similar characteristics with exosomes. Given the similar properties, cell-derived biomimetic nanovesicles could be utilized for drug delivery [24,25], tissue regeneration [26,27], and cancer targeting [28,29]. In particular, it was reported that nanovesicles derived from human tonsil-derived mesenchymal stem cells attenuate liver fibrosis and inflflammation [30,31]. However, the anti-aging effects of nanovesicles derived from human tonsil-derived mesenchymal stem cells (TMSCs) have not yet been investigated. In this study, we examined the question of whether the nanovesicles derived from human tonsil-derived mesenchymal stem cells (TMSC-NVs) have a promising potential to decrease cellular senescence and increase cell proliferation. Both intrinsic replicative senescence and extrinsic ultraviolet B (UV)-irradiated senescence were employed in an in vitro model. TMSC-NVs were applied to these senescence models for assessment of their anti-aging effect.



2. Materials and Methods

2.1. Isolation of Tonsil-Derived Mesenchymal Stem Cells

TMSCs were isolated from human tonsil tissue obtained by tonsillectomy. Human tonsil tissue was washed with phosphate-buffered saline (PBS) (Welgene, Seoul, South Korea) containing 2% antibiotics–antimycotics (Thermo Fisher Scientific, Waltham, MA, USA).

Tissue was chopped and digested using 210 U/mL of collagenase type 1 (Gibco, New York, NY, USA) and 4 KU/mL of DNase 1 (Sigma, St. Louis, MO, USA) in Dulbecco’smodifified Eagle’s medium (DMEM) in low glucose (Gibco, New York, NY, USA) at 37 ◦C for 1 h 30 min. The digested product was filtered through a 40 µm strainer and centrifuged at 1300 rpm for 3 min. The pellet was washed twice with fresh DMEM. Cells were cultured in DMEM containing 10% fetal bovine serum (Gibco, New York, NY, USA) and 1% antibiotics–antimycotics at 37 ◦C and 5% CO2 atmosphere. The media was changed every two days. Flow cytometry with anti-CD90, anti-CD105, and anti-CD73 antibodies (Biolegend, San Diego, CA, USA) was used for the characterization of TMSCs. 

cistanche for skin aging


2.2. Production of Nanovesicles Derived from TMSCs

For the manufacture of the TMSC-derived nanovesicles (TMSC-NVs), TMSCs at passages 2–4 were dissociated with TrypLE express solution (Gibco, New York, NY, USA)

at 37 ◦C for 2 min. TMSCs were suspended with culture media and centrifuged at 1300 rpm for 3 min. The cell pellet was washed twice with PBS and cells was resuspended at a density of 1 × 106cells/mL in PBS. Cells were sequentially passed through filter papers with pore sizes of 10, 5, and 0.4 um using a mini extruder (Avanti polar lipids, Alabaster, AL, USA) to produce cell-derived nanovesicles. The size and shape of TMSC-NVs were determined by dynamic light scattering (DLS) and transmission electron microscopy (TEM), respectively. The concentration of TMSC-NVs was measured using Micro BCA™ Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA) and the senescent cells were treated with 50 µg/mL of TMSC-NVs only once.


2.3. Western Blot

To determine the protein expression of the nanovesicles, cells, and nanovesicles were harvested and lysed in RIPA buffer (Sigma, St. Louis, MO, USA). Lysates were centrifuged at 13,000 rpm for 20 min for the removal of cellular debris. The amount of protein in the supernatant was measured using a Micro BCA™ Protein Assay Kit. An amount of 20 µg of total protein was loaded and separated on a 10% SDS-PAGE gel. After loading, the separated protein was transferred onto a membrane, which was blocked with a 5% BSA solution for 30 min. For immunoblotting, rabbit anti-CD9 (1:2000), anti-CD63 (1:2000), and anti beta-actin (1:5000) primary antibodies (Abcam, Cambridge, UK) were applied at 4 ◦C overnight. For chemiluminescence detection of proteins, HRP-conjugated goat anti-rabbit IgG (H + L) (1:5000) secondary antibody (Invitrogen, Carlsbad, CA, USA) was applied at room temperature for 2 h and Amersham™ ECL Select™ (Thermo Fisher Scientific, Waltham, MA, USA) was used for detection. 



2.4. Cell Culture

HDFs were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in DMEM including 10% fetal bovine serum and 1% antibiotics– antimycotics at 37 ◦C and 5% CO2 atmosphere. The media was changed every two days. Intrinsic replicative senescent cells were produced by repeated passages. Cells with passages 3 and 15 were identified as ‘young’ and ‘old’ states, respectively. Extrinsic senescent cells were treated by UV irradiation with 200 mJ/cm2 of UV.

cistanche for skin aging

2.5. Senescence-Associated β-Galactosidase Assay (SA-β-Galactosidase Assay)

As described by Kurz et al., [32], senescence-associated beta-galactosidase is an enzyme to catalyze the hydrolysis of β-galactosides into monosaccharides. It is detectable in senescent cells and tissues at only pH 6.0, not at pH 4.0. As a biomarker of cellular senescence, its activity can be detected using a chromogenic assay using 5-bromo-4-chloro- 3-indoyl β-D-galactopyranoside (X-gal), which converts to an insoluble blue compound. Here, the SA-β-galactosidase assay was performed using a cellular senescence staining kit (Cell Biolabs, San Diego, CA, USA). All cells were fixed with 0.25% glutaraldehyde solution at room temperature for 5 min. After discarding the fixation solution, each well was gently washed with fresh PBS three times. Cell staining working solution was added, followed by incubation of the cells overnight at 37 ◦C as described. After the reaction of the working solution, the supernatant was discarded and cells were gently washed with PBS two times. Quantitative data were measured by documentation of the colorization ratio of the senescent cells. 



2.6. Immunocytochemistry

To perform the immunocytochemistry, cells were fixed with 4% paraformaldehyde for 30 min. Cells were permeabilized with 0.05% Triton X-100 (Sigma, St. Louis, MO, USA) for 15 min. After permeabilization, cells were blocked with 1% bovine serum albumin (BSA) (Sigma, St. Louis, MO, USA) at room temperature for 30 min, followed by incubation with anti-vinculin (1:200) at room temperature for 1 h. After washing with PBS, goat anti-rabbit IgG H&L Alexa Fluor 488 secondary antibodies and tetramethylrhodamine-conjugated phalloidin (1:200) were applied for 1 h in the dark. To confirm ECM production, cells were fixed, blocked, and incubated with anti-collagen 1 primary antibody (1:200) for 1 h, and goat anti-rabbit IgG H&L Alexa Fluor 488 (1:200). All antibodies used for immunocytochemistry were purchased from Abcam (Cambridge, MA, USA). Immunocytochemistry was counterstained with DAPI nuclear staining and examined under a ZEISS LSM700 confocal microscope (Zeiss, Oberkochen, Germany). 



2.7. Quantitative Real-Time Polymerase Chain Reaction (qPCR)

To confirm the RNA expression of the cells, total RNA was extracted using Trizol reagent (Ambion, Waltham, MA, USA). Six days after treatment with TMSC-NV, 500 µL of Trizol reagent was applied to lyse the cells. Reagent was treated with 100 µL of chloroform (Sigma, St. Louis, MO, USA) and incubated on ice for 15 min. After incubation samples were centrifuged at 13,000 rpm for 15 min and transparent supernatant was obtained. The supernatant was treated with the same volume of isopropanol (Sigma, St. Louis, MO, USA), incubated at room temperature for 15 min, and centrifuged at 1300 rpm for 15 min for precipitation of RNA. The concentration of total RNA was measured using NanoDrop 2000 (Thermo Fisher Scientific, Waltham, MA, USA) and 1 µg of total RNA was used for cDNA synthesis with the SuperScript™ III First-Strand Synthesis System (Invitrogen, Carlsbad, CA, USA) according to the described procedure. Power SYBR™ Green PCR Master Mix

(Applied Biosystems, San Francisco, CA, USA) was used in the performance of qPCR and the reaction was measured using the StepOnePlus real-time PCR system (Applied Biosystems, San Francisco, CA, USA). 

cistanche for skin aging


2.8. Statistical Analysis

All experiments in this study were repeated at least three times. All graphs in this study were drawn using GraphPad Prism 5 software (GraphPad Software Inc., San Diego, CA, USA) and are presented as mean ± SEM. Signifificant differences were determined using one-way ANOVA analysis (* p < 0.05, ** p < 0.01, *** p < 0.001). 




cistanche for skin aging

cistanche for skin aging

Figure 1. Production of nanovesicles derived from tonsil-derived mesenchymal stem cells (TMSC-NVs). (a) Morphology of human tonsil-derived mesenchymal stem cells, scale bar = 200 µm. (b) Expression of surface markers of human tonsil-derived mesenchymal stem cells. (c) Protein expression and SEM image of TMSC-NVs. Protein level was normalized by β-actin. (d) Analysis of dynamic light scattering of TMSC-NVs.



3.2. Anti-Aging Effect of TMSC-NVs in the Passage-Associated Senescence Model

To confirm the anti-aging properties, TMSC-NVs were added to the passage-associated senescence model and cell morphology and proliferation were observed (Figure 2a,b)As shown in Figure 2a,b, treatment with TMSC-NVs increased the cell proliferation of old HDFs. We performed an SA-B-galactosidase assay to confirm the anti-aging role ofIMSC-NVs (Figure 2c). The results show that treatment with TMSC-NVs decreased the Bgalactosidase activity of old HDFs. Quantitative data from the SA-B-galactosidase as. say showed that the ratio of senescent cells was reduced by treatment with TMSC-NVswhich supported that treatment with TMSC-NVs decreased the senescence level of HDFs

Figure 2d). Additionally the protein expression of vinculin in focal adhesion and the morphological change in the actin cytoskeleton followed by treatment with TMSC-NVs was examinedFigure 2e,f). The results of the immunofluorescence analysis show increased commitment of vinculin in focal adhesion in old HDFs, which was decreased by treatment with TMSCNVs. These results show that TMSC-NVs increase the proliferation of HDEs and decrease the senescence induced by passages.


cistanche for skin aging

Figure 2. Regulation of proliferation and senescence by treatment with TMSC-NVs in the passage-associated senescence model. (a) Morphological change in HDFs. Scale bar = 200 um. (b) Proliferation test of passage-associated senescent HDF after treatment with TMSC-NVs. (C) Senescence-associated (SA) B-galactosidase assay, scale bar = 200 um. (d) Quantitative analysis of the SA-B-galactosidase assay.(e) Expression of vinculin in focal adhesion of HDFs. (f) Quantitative data of vinculin expression in focal adhesion. Significant differences among groups were determined by one-way ANOVA(ns > 0.05,*p < 0.05,** p < 0.01,*** p < 0.001)

cistanche for skin aging


3.3. Regulation of extracellular Matrix and Anti-Oxidant Gene by TMSC-NVs in the thePassage-Associated Senescence Model

To confirm the anti-aging properties of TMSC-NVs in terms of molecular biology the gene expression of the extracellular matrix (ECM) production and senescence-related anti-oxidant gene followed by TMSC-NVs treatment was examined (Figure 3a). The mRNA level of collagen type 1 (COL1) and ELASTIN, which is decreased in old HDFs compared to young HDFs, showed that treatment with TMSC-NVs resulted in upregulated ECM production. Similarly, the mRNA expression of SOD2 and HMOX1, the anti-oxidant gene, was increased by treatment with TMSC-NV in old HDFs. In addition, the protein expression of COL1 examined by immunofluorescence showed that treatment with TMSC-NVs resulted in significantly increased ECM production in the passage-associated senescent HDFsFigure 3b,c). According to these results, treatment with TMSC-NVs resulted in recovery of the ECM production and senescence-reducible anti-oxidant gene in senescent cells













You Might Also Like